SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (2295)10/25/1998 11:27:00 AM
From: Kash Khorasani  Respond to of 4676
 
To All:

Anyone has any info/update on the status of negotiations
between ISIS and Novartis vis-a-vi
their "expanded collaborative research program
with Novartis" as mentioned in their 10-K Form of
December 31, 1997? As they indicated "either company
may end the collaborative research program beginning
in September 1998, with certain exceptions" (pp. 11).
Does the lack of any news imply that the collaborations
are continuing? If so, I am still interested in knowing the
nature and extend of their new collaborations.

Thanks


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News